Sos, M. L., Koker, M., Weir, B. A., Heynck, S., Rabinovsky, R., Zander, T., et al. (2009). PTEN Loss Contributes to Erlotinib Resistance in EGFR-Mutant Lung Cancer by Activation of Akt and EGFR. Cancer Research, 69(8): 1, pp. 3256-3261. Retrieved from http://dx.doi.org/10.1158/0008-5472.CAN-08-4055.